The DOI matches its Crossref record; 73 of the 76 references it cites were found in a registry or an index.
Nmnat Delays Axonal Degeneration Caused by Mitochondrial and Oxidative Stress
Open accessAbstract
Axonal degeneration is a prominent feature of many neurological disorders that are associated with mitochondrial dysfunction, including Parkinson's disease, motor neuron disease, and inherited peripheral neuropathies. Studies of the Wld s mutant mouse, which undergoes delayed Wallerian degeneration in response to axonal injury, suggest that axonal degeneration is an active process. Wld s mice also have slower axonal degeneration and disease progression in numerous models of neurodegenerative disease. The Wld s mutation results in the production of a chimeric protein that contains the full-length coding sequence of nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1), which alone is sufficient for axonal protection in vitro . To test the effects of increased Nmnat expression on axonal degeneration induced by mitochondrial dysfunction, we examined dorsal root ganglion (DRG) neurons treated with rotenone. Rotenone induced profound axonal degeneration in DRG neurons; however, this degeneration was delayed by expression of Nmnat. Nmnat-mediated protection resulted in decreased axonal accumulation and sensitivity to reactive oxygen species (ROS) but did not affect the change in the rate of rotenone-induced loss in neuronal ATP. Nmnat also prevented axonal degeneration caused by exposure to exogenous oxidants and reduced the level of axonal ROS after treatment with vincristine, further supporting the idea that Nmnat promotes axonal protection by mitigating the effects of ROS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mammals, over-expressing NMNATs significantly delays Wallerian degeneration of peripheral nerves (28)(29)(30)(31)(32)(33).”
From CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy (2012) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Interestingly, NMNAT over-expression can prevent axonal damage resulting from exogenous application of oxidants (28).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Thiruchelvam, M., Prokopenko, O., Cory-Slechta, D., Richfield, E., Buckley, B., & Mirochnitchenko, O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500417200 · Cited by 84 · cited 1×
“Protection of oxidant-mediated axonal damage by Nmnat suggested that it might act via increasing neuronal expression of antioxidant proteins, including superoxide dismutase, glutathione peroxidase, and/or catalase (Thiruchelvam et al., 2005; Fernandez-Gomez et al., 2006; Jung et al., 2007).”
BackgroundRetractedMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 4×
“Mitochondrial dysfunction caused by mutations or toxic agents has been implicated in many neurodegenerative diseases, including those associated with axonal degeneration (Lin and Beal, 2006).”
BackgroundInfluentialChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · cited 2×
“, DJ-1 and PINK-1) (Martin, 2006) and ingestion of 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine (MPTP), an inhibitor of mitochondrial complex I (Langston et al., 1983; Betarbet et al., 2000).”
BackgroundChronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,770 · cited 8×
“…Parkinson’s disease (PD), which can be associated with mutations in mitochondria-associated proteins (e.g., DJ-1 and PINK-1) (Martin, 2006) and ingestion of 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine (MPTP), an inhibitor of mitochondrial complex I (Langston et al., 1983; Betarbet et al., 2000).”
BackgroundMethodResultInfluentialDopamine (3-hydroxytyramine) and brain function.
Hornykiewicz, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,389 · cited 2×
“…chronic rotenone model of PD, which more closely mimics the degenerative progression observed in PD patients, because this model only works in rats (Hornykiewicz, 1966; Betarbet et al., 2000; Richter et al., 2007); however, our results suggest that increasing Nmnat expression in this model may…”
ResultMechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T., Betarbet, R. S., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno‐Yagi, A., & Greenamyre, J. T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,102 · cited 6×
“The suppression of ROS accumulation by Nmnat proteins is reminiscent of that observed in cells treated with antioxidants, whose utility in preventing axonal degeneration secondary to mitochondrial inhibition has been suggested by others (Sherer et al., 2003, 2007; Testa et al., 2005).”
BackgroundMethodInfluentialIncreased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060 · cited 13×
“…axonal degeneration resulting from damage caused by mechanical, genetic, or chemical injury (Gillingwater and Ribchester, 2001; Wang et al., 2001a,b; Ferri et al., 2003; Samsam et al., 2003; Araki et al., 2004; Gillingwater et al., 2004; Mi et al., 2005; Sasaki et al., 2006; Zhai et al., 2006).”
BackgroundMethodResultInfluentialSelf-citationAxon degeneration mechanisms: Commonality amid diversity
Coleman, M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1788 · Cited by 819 · cited 2×
“These changes are followed by calpain activation and eventual axonal protein degradation (Coleman, 2005).”
BackgroundKeeney, P. M., Xie, J., Capaldi, R., & Bennett, J. P. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0984-06.2006 · Cited by 765 · cited 3×
“For example, complex I inhibition and oxidative damage to mitochondrial proteins have been observed in brains of PD patients, changes that can be replicated by treatment of isolated mitochondria with rotenone (Keeney et al., 2006).”
BackgroundThe risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living
Gorell, J., Johnson, C. C., Rybicki, B., Peterson, E., & Richardson, R. (1998) · Neurology · doi:10.1212/wnl.50.5.1346 · Cited by 694 · cited 1×
“…of PD (Sherer et al., 2002a); in particular, there is a strong association between PD and exposure to pesticides, including many that inhibit mitochondrial complex I (Semchuk et al., 1992; Gorell et al., 1998, 2004; Priyadarshi et al., 2000, 2001; Ascherio et al., 2006; Brown et al., 2006).”
Background
Cited by
Sorted by citations
Items 101–136 of 136
Lee, S. H., Tonello, R., Lee, K., Roh, J., Prudente, A. S., Kim, Y. H., Park, C., & Berta, T. (2024) · Brain · doi:10.1093/brain/awae341 · Cited by 14
“44 Additionally, immunofluorescent staining with the protein gene product 9.5 (PGP9.”
InfluentialKievit, B., Johnstone, A. D., Gibon, J., & Barker, P. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.852181 · Cited by 16
“Mitochondrial Reactive Oxygen Species Is Required Following Axotomy for Late-Stage Ca2+ Flux in Distal Axons Because TRPV1 can be directly regulated by redox state and reactive oxygen species (ROS) have been implicated in postaxotomy events (Press and Milbrandt, 2008; Welin et al., 2009; O’Donnell et al., 2013; Wakats…”
BackgroundSansa, A., de la Fuente, S., Comella, J. X., Garcerá, A., & Soler, R. M. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105366 · Cited by 17
“Morphometric analysis of neurite degeneration was performed as described (Press and Milbrandt, 2008), with modifications.”
MethodCNTF, STAT3 and new therapies for axonal degeneration: what are they and what can they do?
Selvaraj, B. T., & Sendtner, M. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.9 · Cited by 11
Parsons, R. B., Kocinaj, A., Ruiz-Pulido, G., Prendergast, S. A., Parsons, A. E., Facey, P. D., & Hirth, F. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac077 · Cited by 13
“NMNAT3 expression in dorsal root ganglia neurones also decreased axonal reactive oxygen species levels and protected against the toxicity of both rotenone and vincristine (23), and NMNAT3 was also able to protect axons of retinal ganglion RGC-5 cells (60).”
BackgroundPottorf, T. S., Mann, A., Fross, S., Mansel, C. O., & Vohra, B. P. S. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.09.010 · Cited by 11
“cytNmnat1 mediated axon protection is also independent of NAD and ATP levels (Sasaki et al., 2009; Press and Milbrandt, 2008).”
BackgroundHung, S. W., Liang, B., Gao, Y., Zhang, R., Tan, Z., Zhang, T., Chung, J. P. W., Chan, T. H., & Wang, C. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.714790 · Cited by 14
“However, they do not consume NADH and for conversion to NADPH, which is a cofactor of ROS-scavenging enzymes (Mazzio and Soliman, 2003; Press and Milbrandt, 2008).”
BackgroundVirga, D. M., Capps, J., & Vohra, B. P. S. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2649-x · Cited by 10
Narne, P., & Phanithi, P. B. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01287-4 · Cited by 9
“This, however is not accompanied by neuronal ATP preservation (Press and Milbrandt 2008).”
BackgroundAngeletti, C., Amici, A., Gilley, J., Loreto, A., Trapanotto, A. G., Antoniou, C., Coleman, M., & Orsomando, G. (2021) · bioRxiv · doi:10.1101/2021.07.14.451805 · Cited by 9
“and indeed activation of Wallerian degeneration by vincristine does cause an increase in ROS [58].”
BackgroundInfluentialThe purine nucleosides adenosine and guanosine delay axonal degeneration in vitro
Press, C. A., & Milbrandt, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06002.x · Cited by 7
“Nmnat1 (or Nmnat3) overexpression alone is sufficient to slow axonal degeneration and this protection is dependent on Nmnat enzymatic activity (Araki et al. 2004; Wang et al. 2005; Sasaki et al. 2006; Press and Milbrandt 2008).”
BackgroundSelf-citationRahimi, G., Silverman, M., Lucas, M., Kazerooni, L., Yousuf, M. M., Jafarpour, S., & Santoro, J. D. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1538358 · Cited by 9
“This oxidative stress exacerbates inflammation and contributes to axonal damage and degeneration (48).”
Molecular aspects of optic nerve autophagy in glaucoma
Kitaoka, Y., & Sase, K. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101217 · Cited by 8
Pinkerton, M., Ruetenik, A., Bazylianska, V., Nyvltova, E., & Barrientos, A. (2020) · bioRxiv · doi:10.1101/2020.10.27.357780 · Cited by 8
Gliga, A., Taj, T., Wahlberg, K., Lundh, T., Assarsson, E., Hedmer, M., Albin, M., & Broberg, K. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00422 · Cited by 8
“Current snus use 16 (29) 12 (18) 16 (29) 11 (17) 32 (32) 21 (24) 1 1”
BackgroundProgrammed axon degeneration: mechanism, inhibition and therapeutic potential
Loreto, A., & Neukomm, L. J. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00986-3 · Cited by 8
Miralles, M. P., Sansa, A., Beltran, M., Soler, R., & Garcerá, A. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1054270 · Cited by 7
“Morphometric analysis of neurite degeneration was performed as described (Press and Milbrandt, 2008) with modifications.”
MethodMicroRNA miR-1002 Enhances NMNAT-Mediated Stress Response by Modulating Alternative Splicing
Park, J., Zhu, Y., Tao, X., Brazill, J. M., Li, C. V., Wuchty, S., & Zhai, R. G. (2019) · iScience · doi:10.1016/j.isci.2019.08.052 · Cited by 4
“…proteins are essential for neuronal maintenance and protection (Ali et al., 2012; Brazill et al., 2017; Fang et al., 2012; Kitaoka et al., 2013; Press and Milbrandt, 2008; Rossi et al., 2018; Sasaki and Milbrandt, 2010; Sasaki et al., 2009; Wen et al., 2011; Yan et al., 2010; Zhai et al.,…”
BackgroundAvian axons undergo Wallerian degeneration after injury and stress
Bramley, J. C., Collins, S. V. A., Clark, K. B., & Buchser, W. (2016) · Journal of Comparative Physiology A · doi:10.1007/s00359-016-1123-y · Cited by 6
“In addition to taxol, we also used the vinca alkaloid derivative vincristine to induce axon degeneration (Wang et al. 2001; Press and Milbrandt 2008; Barrientos et al. 2011; Park et al. 2013; Gerdts et al. 2013).”
MethodZhang, Z.-W., Qin, X.-Y., Che, F., Xie, G., Shen, L., & Bai, Y.-Y. (2015) · Genetics and Molecular Research · doi:10.4238/2015.october.28.17 · Cited by 7
“In addition, cells undergo oxidative stress during the initial and developmental stages of MS. Mitochondria are the main source of cellular reactive oxygen species (Kutzelnigg et al., 2005; Press and Milbrandt, 2008).”
BackgroundLu, S., Qiu, S., Yu, G., Zhang, A., & Zhao, Q. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103097 · Cited by 8
Tau-mediated axonal degeneration is prevented by activation of the WldS pathway
Stubbs, K., Batchelor, B. G., Sivanantharajah, L., Sealey, M. A., Moreno, M. R., Ruiz, E., Richardson, B., Perry, V. H., Newman, T. A., & Mudher, A. K. (2023) · Brain Communications · doi:10.1093/braincomms/fcad052 · Cited by 9
“…indirectly due to downstream neuroprotective effects of Wld S pathway activation, such as enhanced mitochondrial calcium buffering, 73 or reduced oxidative stress 74 negating tau-mediated dysregulation in intracellular calcium and/or tau-mediated mitochondrial dysfunction 70,75 or oxidative stress.”
Tri-ortho-cresyl phosphate induces axonal degeneration in chicken DRG neurons by the NAD+ pathway
Sun, Y., & Wu, Y. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.05.007 · Cited by 7
Glycolytic System in Axons Supplement Decreased ATP Levels after Axotomy of the Peripheral Nerve
TAKENAKA, T., Ohnishi, Y., Yamamoto, M., Setoyama, D., & Kishima, H. (2023) · eNeuro · doi:10.1523/eneuro.0353-22.2023 · Cited by 5
“The concentrations of inhibitors were determined from previous studies (Press and Milbrandt, 2008; Miranda-Goncalves et al., 2013; Tsuyama et al., 2013; Patterson et al., 2014; Anamitra Ghosh, 2016; Ichihara et al., 2017; Babetto et al., 2020).”
MethodTargeted deletion of Nmnat1 in mouse retina leads to early severe retinal dystrophyPreprint
Wang, X., Yu, F. H. Z., Liao, R., & Wang, T. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/210757 · Cited by 2
“The axon protection conferred by NMNAT1 seems to be closely related to mitochondria, which is a critical organelle for the maintenance of redox state (59, 60).”
BackgroundLu, X.-Q., Zhang, R.-Y., Xu, X.-W., Guang, Y., & Miao, C.-Y. (2010) · Academic Journal of Second Military Medical University · doi:10.3724/sp.j.1008.2010.01251 · Cited by 2
Alizarin Red perturbs skeletal patterning and biomineralization via catalase inhibition
Descoteaux, A. E., Radulovic, M., Mahoney, E., Ghogale, M., Chandragiri, S., Abayawardena, D., Shrestha, B. D., Wikramanayake, A. H., Prakash, V. N., & Bradham, C. A. (2026) · Development · doi:10.1242/dev.205079 · Cited by 1
Tau-mediated axonal degeneration is prevented by activation of the WldS pathway
Stubbs, K., Sealey, M., Moreno, M. R., Perry, V. H., Newman, T. A., & Mudher, A. (2020) · bioRxiv · doi:10.1101/2020.12.06.408583 · Cited by 1
“Alternatively, protection may be conferred 399 indirectly due to downstream neuroprotective effects of WldS pathway activation, such as 400 enhanced mitochondrial calcium buffering (66), or reduced oxidative stress (67) negating tau401 mediated dysregulation in intracellular calcium and/or tau-mediated mitochondrial d…”
BackgroundSadikoglou, E., Domingo-Fernándéz, D., Savytska, N., Fernandes, N., Rizzu, P., Illarionova, A., Strauß, T., Schwarz, S., Kodamullil, A., Höglinger, G. U., et al. (2022) · bioRxiv · doi:10.1101/2022.11.07.515284
“We observed axonal degeneration and microtubules bundles disarrangement prior to cellular death, which is in good agreement with previous oxidative stress (OS) studies (Press and Milbrandt, 2008; Fang et al. , 2012; Barsukova et al. , 2012; Datar et al. , 2019).”
Manifestations of Drug Toxicity on Mitochondria in the Nervous System
Prehn, J. H. M., & Llorente‐Folch, I. (2018) · Wiley eBooks · doi:10.1002/9781119329725.ch9
The cellular and molecular mechanisms of axonal maintenance and regeneration
Coakley, S. (2014) · doi:10.14264/uql.2015.153
“Neurons are particularly susceptible to this damage and increased ROS has been shown to induce Wallerian degeneration in axons (Press and Milbrandt, 2008).”
Fusion Models and “Fusioning” in Parkinsonism: Protection and Restoration by Exercise
Archer, T., & Fredriksson, A. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_95
dSarm/Sarm1 Governs a Conserved Axon Death Program: A Dissertation
Osterloh, J. M. (2013) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2xs4z
“These discrepancies were eventually rectified when groups looked at the effect of other Nmnat1 homologs on Wallerian degeneration.”
BackgroundInfluentialAntenor‐Dorsey, J. A. V. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7h70cv2
“Although we could confirm our cell body results, we could not quantitate ROS changes in DA axons with these reagents (data not shown).”
BackgroundInfluentialAxon Death Prevented: Wlds and Other Neuroprotective Molecules: A Dissertation
Avery, M. A. (2010) · eScholarship@UMassChan · doi:10.13028/ejya-6w71
Characterization of the role for Nmnat, kinase cascades, and purines in axonal degeneration
Press, C. A. (2010) · doi:10.7936/k7sb43rf
Self-citation
Metadata
- Authors
- Press, C., & Milbrandt, J.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Milbrandt, Jeffrey
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-05-07
- Volume
- 28
- Issue
- 19
- Pages
- 4861-4871
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2678678
- OpenAlex
- W2046359526
- Cited by
- 137
- References
- 76
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 7 · 2021: 9 · 2020: 4 · 2019: 10 · 2018: 5 · 2017: 5 · 2016: 8 · 2015: 8 · 2014: 11 · 2013: 11 · 2012: 11
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Muscular Dystrophy Association
- Hope Center for Neurological Disorders
- National Institutes of Health (AG13730, NS057105)
- National Institute on Aging (AG 13730, RF1AG013730, R56AG013730, R01AG013730)
- National Institute of Neurological Disorders and Stroke (NS39358, P30NS057105, NS057105, R01NS039358)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- NMNAT1, nicotinamide mononucleotide adenylyltransferase, axonal degeneration, Wallerian degeneration, rotenone, mitochondrial dysfunction, oxidative stress, reactive oxygen species, dorsal root ganglion neurons, axonal protection, vincristine, ATP depletion
- MeSH terms
- Adenosine Triphosphate, Animals, Antioxidants, Axons, Cells, Cultured, Ganglia, Spinal, Isoenzymes, Nerve Degeneration, Neurons, Nicotinamide-Nucleotide Adenylyltransferase, Rotenone, Stress, Physiological, Vincristine, Down-Regulation, Rats, Sprague-Dawley, Gene Transfer Techniques, Oxidative Stress, Mitochondrial Diseases, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review